COMPANY

Innoblative Designs, Inc.

HQ: Chicago, IL source · innoblative.com ↗ · Midwest

Also known as Innoblative Designs · 2 sources

Location: Chicago, IL · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Breast Cancer Breast-conserving Surgery ER/PR+Her2neu Grade I, II, III Prophylactic Mastectomy

Timeline

Feb 10, 2026 Trial start Not phased (device or behavioral study): Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery source ↗
Jul 20, 2016 Trial start —: Feasibility Study of Cavitary Radiofrequency Ablation in Excised Mastectomy Breast Tissue source ↗

Feb 6, 2027 (ESTIMATED) · Not phased · Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery · NCT07206121

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07206121	Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery	Not phased (device or behavioral study)	Recruiting	Feb 10, 2026	Feb 6, 2027 (estimated)
NCT02614885	Feasibility Study of Cavitary Radiofrequency Ablation in Excised Mastectomy Breast Tissue	Not listed	Completed	Jul 20, 2016	Jun 15, 2017 (actual)